BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10535222)

  • 21. Long-term effects of heroin-assisted treatment in Germany.
    Verthein U; Bonorden-Kleij K; Degkwitz P; Dilg C; Köhler WK; Passie T; Soyka M; Tanger S; Vogel M; Haasen C
    Addiction; 2008 Jun; 103(6):960-6; discussion 967-8. PubMed ID: 18422829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up.
    Güttinger F; Gschwend P; Schulte B; Rehm J; Uchtenhagen A
    Eur Addict Res; 2003 Apr; 9(2):73-9. PubMed ID: 12644733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathways into receiving a prescription for diamorphine (heroin) for the treatment of opiate dependence in the United kingdom.
    Metrebian N; Mott J; Carnwath Z; Carnwath T; Stimson GV; Sell L
    Eur Addict Res; 2007; 13(3):144-7. PubMed ID: 17570910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Heroin-assisted treatment of opiate dependent patients. Experiences from Swiss trials for medical prescription of narcotics (PROVE)].
    Steffen T; Uchtenhagen A; Gutzwiller F; Dobler-Mikola A; Blättler R
    Internist (Berl); 1999 Jun; 40(6):651-6. PubMed ID: 10420321
    [No Abstract]   [Full Text] [Related]  

  • 25. [Development of skin diseases in intravenous drug dependent patients treated with heroin substitution].
    Conrad C; Steffen T; Gutzwiller F
    Praxis (Bern 1994); 2000 Nov; 89(46):1899-906. PubMed ID: 11111408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological abnormalities in opiate addicts with and without substitution therapy.
    Paur R; Wallner C; Hermann P; Stöllberger C; Finsterer J
    Am J Drug Alcohol Abuse; 2012 May; 38(3):239-45. PubMed ID: 22263960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of qigong therapy in the detoxification of heroin addicts.
    Li M; Chen K; Mo Z
    Altern Ther Health Med; 2002; 8(1):50-4, 56-9. PubMed ID: 11795622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of personality traits and drug of choice by cocaine addicts and heroin addicts.
    Gerra G; Bertacca S; Zaimovic A; Pirani M; Branchi B; Ferri M
    Subst Use Misuse; 2008; 43(3-4):317-30. PubMed ID: 18365934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy diacetylmorphine (pharmaceutical heroin) for heroin treatment ].
    Demaret I; Lemaître A; Ansseau M
    Rev Med Liege; 2010 Dec; 65(12):681-7. PubMed ID: 21287763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Review of scientific evidence on alternatives to methadone in the psychopharmacologic treatment of opiate dependence].
    Iruín A; Aizpurua I; Ruiz de Apodaka J; Zapiraín E; Aizpuru A
    Rev Esp Salud Publica; 2001; 75(3):207-19. PubMed ID: 11515335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
    Duburcq A; Charpak Y; Blin P; Madec L
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The prevalence of psychiatric co-morbidity among opioid addicts].
    Frei A; Rehm J
    Psychiatr Prax; 2002 Jul; 29(5):258-62. PubMed ID: 12101492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Personality changes in opioid-dependent subjects in a methadone maintenance treatment program].
    Trémeau F; Darreye A; Leroy B; Renckly V; Ertlé S; Weibel H; Khidichian F; Macher JP
    Encephale; 2003; 29(4 Pt 1):285-92. PubMed ID: 14615698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study.
    Gerra G; Leonardi C; D'Amore A; Strepparola G; Fagetti R; Assi C; Zaimovic A; Lucchini A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):265-72. PubMed ID: 16309810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complaints of heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine.
    Dürsteler-MacFarland KM; Stohler R; Moldovanyi A; Rey S; Basdekis R; Gschwend P; Eschmann S; Rehm J
    Drug Alcohol Depend; 2006 Feb; 81(3):231-9. PubMed ID: 16135401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical prescription of heroin to chronic heroin addicts in Switzerland - a review.
    Brehmer C; Iten PX
    Forensic Sci Int; 2001 Sep; 121(1-2):23-6. PubMed ID: 11516883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Addiction characteristics as prognostic factors in opiate dependence treated with naltrexone].
    Madoz-Gúrpide A; Barbudo del Cura E; Leira Sanmartín M; Navio Acosta M; Villoria Borrego L; Ochoa Mangado E
    Actas Esp Psiquiatr; 2004; 32(4):199-210. PubMed ID: 15232748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dutch research on the effectiveness of medical prescription of heroin; background, research design and preliminary results].
    van den Brink W; Hendriks VM; Blanken P; van Ree JM
    Ned Tijdschr Geneeskd; 2000 Jan; 144(3):108-12. PubMed ID: 10674115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescribing heroin.
    Carnwath T
    Am J Addict; 2005; 14(4):311-8. PubMed ID: 16188711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innovations in agonist maintenance treatment of opioid-dependent patients.
    Haasen C; van den Brink W
    Curr Opin Psychiatry; 2006 Nov; 19(6):631-6. PubMed ID: 17012944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.